Should We Perform Carotid Stenting?
Trevor Cleveland FRCS FRCR
Consultant Vascular Radiologist
Sheffield Vascular Institute
Sheffield Teaching Hospitals
Herries Road
Sheffield S5 7AU
Telephone number: 0114 2269256
Fax: 0114 2714747
E-mail: Trevor.Cleveland@sth.nhs.uk
Abstract
Carotid artery stenting (CAS) is an evolving technique, primarily directed at the carotid artery bifurcation. It is, however, also applicable to other regions of the carotid arteries, and has been utilised successfully in these regions for a number of years. There are several randomised trials comparing carotid endarterectomy (CEA) with CAS in patients considered suitable for both procedures, the conclusions from which are not clear cut. There have been some suggestions that CAS should not be performed; the reasons for this are discussed in this article and the evidence considered critically. CAS is a procedure which may be of benefit to patients, and those suitable should have timely access to it.
Trevor Cleveland is Consultant Vascular Radiologist at the Sheffield Vascular Institute. He qualified as a doctor in 1985, and after pre-registration training followed a basic training in surgery, and obtained Fellowship of the Royal College of Surgeons of England in 1990. He then underwent Clinical Radiology training, gaining accreditation in 1995. He was appointed Senior Lecturer in Vascular Radiology at the University of Sheffield in 1995, transferring to his present full-time National Health Service post in 2000. During this time he has published more than 65 scientific and review papers in peer-reviewed journals, has written book chapters, and contributed to national and international guidance documents. He has delivered over 150 lectures at national and international meetings.
Read also - related articles
Management of bifurcation lesions
Author: Azeem Latib and Antonio Colombo
Coronary bifurcations are frequently encountered by interventional cardiologists and remain a challenging subset of lesions to treat. Recent advances in percutaneous coronary intervention and the introduction of drug-eluting stents have dramatically improved our ability to successfully treat patients percutaneously, with improved long-term results. Read more...
Left main stem stenting
Author: Anthony H Gershlick
Percutaneous treatment of obstructive coronary disease has, for a number of years, been undertaken more commonly than the coronary artery bypass graft (CABG). Technical developments, operator skill and the advent of drug-eluting stents has meant that most lesions can be treated effectively with little associated morbidity and with rapid patient discharge. Read more...
Role of diagnostic radiology in the management of acute stroke
Author: Imanuel Dzialowski, Rüdiger von Kummer
This article discusses the clinical efficacy of diagnostic imaging in acute stroke. It compares computed tomography (CT) with magnetic resonance imaging (MRI) according to six different levels of clinical efficacy. Read more...
Carotid artery stenting without cerebral protection
Author: Arnd Doerfler, Tobias Engelhorn and Michael Forsting
Carotid angioplasty and stenting is increasingly used as an attractive alternative to carotid endarterectomy (CEA) for treatment of symptomatic and asymptomatic carotid artery disease. Read more...
Use of cerebral protection during carotid artery stenting
Author: Bernhard Reimers
Carotid artery stenting (CAS) is emerging as a less invasive alternative to carotid endarterectomy, although embolic neurological events occur invariably during CAS. Read more...
The balance of evidence for carotid artery stenting with cerebral protection
Author: Antonio Colombo and
Ioannis Iakovou
Although endarterectomy is today considered the gold-standard therapy for the treatment of carotid artery stenosis, the approach is not free of complications. Carotid artery stenting (CAS) has rapidly emerged as an equivalent alternative to Read more...
New stent technologies: coated, covered and bifurcated stents
Author: Chidambaram Rammohan,
Ata Erdogan and
Charles J. Davidson
Specific anatomic challenges and in-stent restenosis have been the impetus for new designs in stent technology. Drug-eluting stents, particularly the sirolimus-coated and paclitaxel-coated stents have shown efficacy in clinical trials. Read more...
